We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Vertebroplasty Is Safe and Effective for Treating Vertebral Compression Fractures

By HospiMedica International staff writers
Posted on 26 Aug 2010
A new study that contradicts previous findings once again supports the idea that vertebroplasty is safe, effective, and gives greater pain relief than regular conservative treatment in patients with acute osteoporotic vertebral compression fractures. More...


Researchers at St Elisabeth Ziekenhuis (Tilburg, The Netherlands) and University Medical Center Utrecht (The Netherlands) conducted a randomized trial that recruited 431 patients from the radiology departments of six hospitals in the Netherlands and Belgium, between Oct 1, 2005, and June 30, 2008. The patients were aged 50 years or older, had vertebral compression fractures evident on spine radiographs, and had experienced back pain for six weeks or less with a visual analogue scale (VAS) score of five or more. The primary outcome was pain relief at one month and one year, as measured by VAS score. Clinically significant pain relief was defined as a decrease in VAS score from baseline of three points or more; pain-free days were defined as days with a VAS score of three or lower.

The results showed that 229 (53%) of the patients had spontaneous pain relief during assessment; the other 202 patients with persistent pain were randomly and equally allocated to treatment (101 to vertebroplasty and 101 to conservative treatment). The researchers found that vertebroplasty resulted in greater pain relief than did conservative treatment; difference in mean VAS score between baseline and one month was -5.2 after vertebroplasty and -2.7 after conservative treatment, and between baseline and one year was -5.7 after vertebroplasty and -3.7 after conservative treatment. The difference between groups in reduction of mean VAS score from baseline was 2.6 at one month and 2.0 at one year. No serious complications or adverse events were reported. The study was published ahead of print on August 9, 2010, in the Lancet.

"In a selected subgroup of patients with acute osteoporotic vertebral fractures and persistent pain, vertebroplasty is effective and safe,” concluded lead author Caroline Klazen M.D., and colleagues. "Pain relief after the procedure is immediate, sustained for one year, and is significantly better than that achieved with conservative treatment and at acceptable costs.”

The "vertebroplasty controversy” erupted after two studies that tested vertebroplasty against a placebo were published in the New England Journal of Medicine (NEJM) in August 2009. Many experts were stunned by the results that suggested that patients got the same modest pain relief whether they received vertebroplasty or a dummy injection.

Related Links:
St Elisabeth Ziekenhuis
University Medical Center Utrecht


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.